Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.

Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.

Classical approaches to immunotherapy that show promise in some malignancies have generally been disappointing when applied to high-grade brain tumors such as glioblastoma multiforme (GBM). We recently showed that ex vivo expanded/activated γδ T cells recognize NKG2D ligands expressed on malignant g...

Full description

Bibliographic Details
Main Authors: Lawrence S Lamb, Joscelyn Bowersock, Anindya Dasgupta, G Yancey Gillespie, Yun Su, Austin Johnson, H Trent Spencer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3543433?pdf=render

Internet

http://europepmc.org/articles/PMC3543433?pdf=render

Similar Items